Phyllis A. Gimotty, Ph.D.
Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics (CCEB), University of Pennsylvania Perelman School of Medicine
Department: Biostatistics and Epidemiology
Graduate Group Affiliations
Contact information
Department of Biostatistics, Epidemiology and Informatics
University of Pennsylvania Perelman School of Medicine
423 Guardian Drive, 631 Blockley Hall
Philadelphia, PA 19104-6021
University of Pennsylvania Perelman School of Medicine
423 Guardian Drive, 631 Blockley Hall
Philadelphia, PA 19104-6021
Office: 215-573-5153
Fax: 215-573-4865
Fax: 215-573-4865
Email:
pgimotty@upenn.edu
pgimotty@upenn.edu
Publications
Links
Search PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Search PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Education:
B.A. (Sociology)
University of Michigan, Ann Arbor, MI, 1970.
M.A. (Statistics)
University of Michigan, Ann Arbor, MI , 1972.
Ph.D. (Biostatistics)
University of Michigan, Ann Arbor, MI , 1984.
Permanent linkB.A. (Sociology)
University of Michigan, Ann Arbor, MI, 1970.
M.A. (Statistics)
University of Michigan, Ann Arbor, MI , 1972.
Ph.D. (Biostatistics)
University of Michigan, Ann Arbor, MI , 1984.
Selected Publications
Gimotty PA, Till JE, Udgata S, Takenaka N, Yee SS, LaRiviere MJ, O'Hara MH, Reiss KA, O'Dwyer P, Katona BW, Herman D, Carpenter EL, Zaret KS: Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma. Oncotarget 13: 1187, Nov 2022.Jain V, Harper SL, Versace AM, Fingerman D, Brown GS, Bhardwaj M, Crissey MAS, Goldman AR, Ruthel G, Liu Q, Zivkovic A, Stark H, Herlyn M, Gimotty PA, Speicher DW, Amaravadi RK. . . 2022 Nov 4:CD-22-0535. Online ahead of print. PMID: : Targeting UGCG overcomes resistance to lysosomal autophagy inhibition. Cancer Discovery Page: CD-22-0535, Nov 2022 Notes: doi: 10.1158/2159-8290.CD-22-0535. Online ahead of print.
Bartolo L, Afroz S, Pan YG, Xu R, Williams L, Lin CF, Tanes C, Bittinger K, Friedman ES, Gimotty PA, Wu GD, Su LF: SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens. Science Immunology 7(76): eabn3127, Oct 2022.
Stejerean-Todoran I, Vultur A, Gibhardt CS, Ickes C, Zimmermann K, Cappello S, Li H, Gimotty PA, Herlyn M, Bogeski I: Exploring the role of MCUA and RAC1 in melanoma aggressive behavior. The 19th International Congress of the Society for Melanoma Research Oct 2022.
Sharma G, Ojha R, Noguera-Ortega E, Rebecca VW, Attanasio J, Liu S, Piao S, Lee JJ, Nicastri MC, Harper SL, Ronghe A, Jain V, Winkler JD, Speicher DW, Mastio J, Gimotty PA, Xu X, Wherry EJ, Gabrilovich DI, Amaravadi RK: Erratum in: PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma. JCI Insight 7(20): e165688, Oct 2022.
Stejerean-Todoran I, Gimotty PA, Watters A, Brafford P, Krepler C, Godok T, Li H, Bonilla Del Rio Z, Zieseniss A, Katschinski DM, Sertel SM, Rizzoli SO, Garman B, Nathanson KL, Xu X, Chen Q, Oswald JH, Lotem M, Mills GB, Davies MA, Schön MP, Bogeski I, Herlyn M, Vultur A: A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cell. Neuro-oncology Page: noac212, Sep 2022.
Sannigrahi MK, Rajagopalan P, Lai L, Liu X, Sahu V, Nakagawa H, Jalaly JB, Brody RM, Morgan IM, Windle BE, Wang X, Gimotty PA, Kelly DP, White EA, Basu D: HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PCG-1α/ERRα axis. JCI Insight 7(18): e159600, Sep 2022.
Brody RM, Shimunov D, Cohen RB, Lin A, Lukens JN, Hartner L, Aggarwal C, Duvvuri U, Montone KT, Jalaly JB, LiVolsi VA, Carey RM, Shanti RM, Rajasekaran K, Chalian AA, Rassekh CH, Cannady SB, Newman JG, O'Malley BW, Weinstein GS, Gimotty PA, Basu D. : A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers. Oral Oncology 127: 105798, Apr 2022.
Mehnert JM, Mitchell TC, Huang AC, Aleman TS, Kim BJ, Schuchter LM, Linette GP, Karakousis GC, Mitnick S, Giles L, Carberry M, Frey N, Kossenkov A, Groisberg R, Hernandez-Aya LF, Ansstas G, Silk AW, Chandra S, Sosman JA, Gimotty PA, Mick R, Amaravadi RK: BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma. Clinical Cancer Research 28(6): 1098-1106, Mar 2022.
Miura JT, Lindner H, Karakousis GC, Sharon CE, Gimotty PA: Conditional survival estimates for merkel cell carcinoma reveal the dynamic nature of prognostication. Journal of Surgical Oncology Mar 2022 Notes: doi: 10.1002/jso.26861. Epub ahead of print.